In our in vitro gain and loss of function study, we found that knockdown of SIK2 in GC cells significantly increased expression of EMT markers such as Vimentin and Snail but lost expression of epithelial marker ZO‐1. This evidence concerns the gene SIK2 and gastric cancer.